Ionis Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Ionis Pharmaceuticals
IONS Stock  USD 80.60  1.18  1.44%   
Ionis Pharmaceuticals' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Ionis Pharmaceuticals' valuation are provided below:
Gross Profit
73.7 M
Profit Margin
(0.27)
Market Capitalization
13.1 B
Enterprise Value Revenue
12.7249
Revenue
967 M
There are over one hundred nineteen available fundamental trends for Ionis Pharmaceuticals, which can be analyzed over time and compared to other ratios. All traders should confirm Ionis Pharmaceuticals' regular fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 6.8 B in 2026. Enterprise Value is likely to gain to about 7.8 B in 2026

Ionis Pharmaceuticals Total Revenue

851.45 Million

Check Ionis Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ionis Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 26.6 M, Interest Expense of 109.2 M or Total Revenue of 851.5 M, as well as many indicators such as Price To Sales Ratio of 16.15, Dividend Yield of 0.0 or PTB Ratio of 9.71. Ionis financial statements analysis is a perfect complement when working with Ionis Pharmaceuticals Valuation or Volatility modules.
  
Build AI portfolio with Ionis Stock
Check out the analysis of Ionis Pharmaceuticals Correlation against competitors.
For more information on how to buy Ionis Stock please use our How to Invest in Ionis Pharmaceuticals guide.

Ionis Pharmaceuticals Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.6 B3.5 B1.9 B
Slightly volatile
Short and Long Term Debt Total1.7 B1.6 B803.7 M
Slightly volatile
Total Current Liabilities373.5 M355.7 M220.9 M
Slightly volatile
Total Stockholder Equity710.4 M676.6 M511.3 M
Slightly volatile
Property Plant And Equipment Net309.2 M294.5 M157.3 M
Slightly volatile
Cash473 M278.4 M856.2 M
Pretty Stable
Non Current Assets Total462.9 M440.9 M254.9 M
Slightly volatile
Non Currrent Assets Other104.2 M99.2 M72.2 M
Slightly volatile
Cash And Short Term Investments2.8 B2.6 B1.5 B
Slightly volatile
Common Stock Shares Outstanding86.2 M171.9 M120.7 M
Slightly volatile
Liabilities And Stockholders Equity3.6 B3.5 B1.9 B
Slightly volatile
Non Current Liabilities Total2.5 B2.4 B1.2 B
Slightly volatile
Other Current Assets263.2 M250.6 M112.1 M
Slightly volatile
Other Stockholder Equity3.5 B3.3 B1.8 B
Slightly volatile
Total Liabilities2.9 B2.8 B1.4 B
Slightly volatile
Total Current Assets3.2 B3 B1.7 B
Slightly volatile
Short Term Debt17.1 M10.7 M25.8 M
Pretty Stable
Intangible Assets24.2 M33.4 M23.2 M
Slightly volatile
Accounts Payable51.9 M49.4 M22.7 M
Slightly volatile
Net Receivables111.3 M106 M52.4 M
Slightly volatile
Property Plant And Equipment Gross437.6 M416.8 M190.8 M
Slightly volatile
Short Term Investments2.5 B2.4 B1.1 B
Slightly volatile
Other Assets57.3 M40.2 M74.4 M
Pretty Stable
Long Term Debt1.5 B1.4 B731.9 M
Slightly volatile
Common Stock Total Equity110.1 K163.3 K123.6 K
Slightly volatile
Property Plant Equipment79.6 M85.4 M101.4 M
Pretty Stable
Other Liabilities170 M330.9 M230 M
Slightly volatile
Current Deferred Revenue71.9 M90.8 M81.8 M
Slightly volatile
Inventory9.8 M14.4 M11.7 M
Slightly volatile
Net Tangible Assets531.9 M658.8 M507.2 M
Slightly volatile
Long Term Debt Total1.4 B1.4 B708.8 M
Slightly volatile
Capital Surpluse1.7 B2.4 B1.7 B
Slightly volatile
Deferred Long Term Liabilities96.7 M83.6 M81.9 M
Very volatile
Non Current Liabilities Other654.7 M623.5 M274 M
Slightly volatile
Short and Long Term Debt10.1 M10.7 M25.7 M
Pretty Stable
Net Invested Capital1.9 B2.1 B1.4 B
Slightly volatile
Net Working Capital2.1 B2.7 B1.6 B
Slightly volatile
Capital Stock157.6 K181.7 K143.9 K
Slightly volatile
Deferred Long Term Asset Charges232.6 M261.7 M285.7 M
Slightly volatile
Long Term Investments8 M9 M9.8 M
Slightly volatile

Ionis Pharmaceuticals Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization26.6 M25.3 M14.9 M
Slightly volatile
Total Revenue851.5 M810.9 M512.6 M
Slightly volatile
Other Operating Expenses1.4 B1.4 B665 M
Slightly volatile
Cost Of Revenue12.3 M12.9 M101.9 M
Slightly volatile
Total Operating Expenses1.4 B1.3 B617 M
Slightly volatile
Research Development1.1 B1 B507.5 M
Slightly volatile
Selling General Administrative323 M307.6 M154.7 M
Slightly volatile
Selling And Marketing Expenses22.2 K23.4 K10 M
Slightly volatile
Non Operating Income Net Other193.6 M184.4 M60.3 M
Slightly volatile
Interest Income2.9 M3.1 M10.8 M
Slightly volatile
Reconciled Depreciation19.3 M25.3 M14.3 M
Slightly volatile

Ionis Pharmaceuticals Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow482.1 M459.2 M279.6 M
Slightly volatile
Depreciation23.7 M22.6 M14.5 M
Slightly volatile
Capital Expenditures54.7 M52.1 M24.1 M
Slightly volatile
End Period Cash Flow176.1 M278.4 M264.9 M
Slightly volatile
Stock Based Compensation157.2 M149.7 M91.5 M
Slightly volatile
Issuance Of Capital Stock494 M470.5 M351.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio16.158.5214.8909
Slightly volatile
PTB Ratio9.7110.2217.0722
Slightly volatile
Days Sales Outstanding52.1354.88167
Slightly volatile
Book Value Per Share2.223.543.7122
Slightly volatile
Stock Based Compensation To Revenue0.110.170.1557
Slightly volatile
Capex To Depreciation1.052.071.6404
Very volatile
PB Ratio9.7110.2217.0722
Slightly volatile
EV To Sales17.0610.4415.8904
Slightly volatile
Inventory Turnover0.981.0311.315
Slightly volatile
Days Of Inventory On Hand441366608
Pretty Stable
Payables Turnover0.220.235.0576
Slightly volatile
Sales General And Administrative To Revenue0.180.340.224
Slightly volatile
Research And Ddevelopement To Revenue1.761.471.2138
Pretty Stable
Capex To Revenue0.130.07380.0785
Slightly volatile
Cash Per Share14.5213.839.1631
Slightly volatile
Days Payables Outstanding1.3 K1.3 K1.5 K
Pretty Stable
Intangibles To Total Assets0.01210.01280.0179
Slightly volatile
Current Ratio4.427.626.3223
Slightly volatile
Tangible Book Value Per Share1.983.543.577
Slightly volatile
Receivables Turnover6.546.8826.7239
Slightly volatile
Shareholders Equity Per Share2.123.543.5149
Slightly volatile
Debt To Equity2.062.171.9115
Slightly volatile
Capex Per Share0.290.270.1822
Slightly volatile
Revenue Per Share4.464.243.6276
Slightly volatile
Interest Debt Per Share9.539.075.9592
Slightly volatile
Debt To Assets0.360.420.4149
Pretty Stable
Graham Number10.319.5111.2926
Slightly volatile
Operating Cycle275409558
Very volatile
Price Book Value Ratio9.7110.2217.0722
Slightly volatile
Days Of Payables Outstanding1.3 K1.3 K1.5 K
Pretty Stable
Company Equity Multiplier5.585.874.2904
Slightly volatile
Long Term Debt To Capitalization0.450.610.5436
Slightly volatile
Total Debt To Capitalization0.470.640.586
Pretty Stable
Debt Equity Ratio2.062.171.9115
Slightly volatile
Quick Ratio4.387.596.2722
Slightly volatile
Cash Ratio1.740.91.2716
Very volatile
Days Of Inventory Outstanding441366608
Pretty Stable
Days Of Sales Outstanding52.1354.88167
Slightly volatile
Price To Book Ratio9.7110.2217.0722
Slightly volatile
Fixed Asset Turnover2.172.483.0146
Slightly volatile
Debt Ratio0.360.420.4149
Pretty Stable
Price Sales Ratio16.158.5214.8909
Slightly volatile
Asset Turnover0.180.210.274
Pretty Stable
Price Fair Value9.7110.2217.0722
Slightly volatile

Ionis Pharmaceuticals Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap6.8 B6.5 B7.1 B
Slightly volatile
Enterprise Value7.8 B7.5 B7.6 B
Slightly volatile

Ionis Fundamental Market Drivers

Forward Price Earnings90.9091
Cash And Short Term Investments2.3 B

Ionis Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Ionis Pharmaceuticals Financial Statements

Ionis Pharmaceuticals shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Ionis Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Ionis Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Ionis Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue90.8 M71.9 M
Total Revenue810.9 M851.5 M
Cost Of Revenue12.9 M12.3 M
Stock Based Compensation To Revenue 0.17  0.11 
Sales General And Administrative To Revenue 0.34  0.18 
Research And Ddevelopement To Revenue 1.47  1.76 
Capex To Revenue 0.07  0.13 
Revenue Per Share 4.24  4.46 
Ebit Per Revenue(0.61)(0.64)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Ionis Stock Analysis

When running Ionis Pharmaceuticals' price analysis, check to measure Ionis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ionis Pharmaceuticals is operating at the current time. Most of Ionis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ionis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ionis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ionis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY